An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
Authors
Keywords
-
Journal
Nature Communications
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-12
DOI
10.1038/s41467-023-37697-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
- (2022) Sam Afkhami et al. CELL
- Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
- (2022) Nicole Wolter et al. LANCET
- Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
- (2022) Huiping Shuai et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity
- (2022) Catherine Riou et al. Science Translational Medicine
- Predicting the mutational drivers of future SARS-CoV-2 variants of concern
- (2022) M. Cyrus Maher et al. Science Translational Medicine
- T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
- (2022) Vivek Naranbhai et al. CELL
- Mucosal immune responses to infection and vaccination in the respiratory tract
- (2022) Robert C. Mettelman et al. IMMUNITY
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- T cell responses to SARS-CoV-2 spike cross-recognize Omicron
- (2022) Roanne Keeton et al. NATURE
- Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
- (2022) Paul Elliott et al. SCIENCE
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- COVID-19 vaccination: The road ahead
- (2022) Daniel M. Altmann et al. SCIENCE
- Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
- (2022) Han-Yi Huang et al. Science Translational Medicine
- Covid-19: True global death toll from pandemic is almost 15 million, says WHO
- (2022) Luke Taylor BMJ-British Medical Journal
- Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2022) Fengcai Zhu et al. Lancet Respiratory Medicine
- A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
- (2022) Junyu Chen et al. Science Bulletin
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection
- (2022) Jeffrey L. Americo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
- (2022) Shuofeng Yuan et al. SCIENCE
- How nasal-spray vaccines could change the pandemic
- (2022) Emily Waltz NATURE
- Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
- (2022) Tianyang Mao et al. SCIENCE
- SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
- (2022) Anupriya Aggarwal et al. EBioMedicine
- Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
- (2022) Felicity Liew et al. EBioMedicine
- The success of SARS-CoV-2 vaccines and challenges ahead
- (2021) Kanta Subbarao Cell Host & Microbe
- Scent of a vaccine
- (2021) Frances E. Lund et al. SCIENCE
- A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
- (2021) Traci L. Bricker et al. Cell Reports
- Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
- (2021) Jun Zhang et al. SCIENCE
- Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
- (2021) Runhong Zhou et al. EBioMedicine
- Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA
- (2021) Ji Eun Oh et al. Science Immunology
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2020) Andrew Rambaut et al. Nature Microbiology
- How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines
- (2019) Rajeev Rudraraju et al. JOURNAL OF INFECTIOUS DISEASES
- Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
- (2019) Pui Wang et al. mBio
- Immunomodulatory Nonstructural Proteins of Influenza A Viruses
- (2018) Carolin Klemm et al. TRENDS IN MICROBIOLOGY
- Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells
- (2017) Angela Pizzolla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An A14U Substitution in the 3′ Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs
- (2015) Min Zheng et al. JOURNAL OF VIROLOGY
- NS1-Truncated Live Attenuated Virus Vaccine Provides Robust Protection to Aged Mice from Viral Challenge
- (2012) N. Pica et al. JOURNAL OF VIROLOGY
- Immunization with Live Attenuated Influenza Viruses That Express Altered NS1 Proteins Results in Potent and Protective Memory CD8+ T-Cell Responses
- (2009) S. N. Mueller et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started